CRON: Cronos Group Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 692.38
Enterprise Value ($M) -119.51
Book Value ($M) 1,110.98
Book Value / Share 2.90
Price / Book 0.62
NCAV ($M) 880.78
NCAV / Share 2.30
Price / NCAV 0.79

Profitability (mra)
Return on Invested Capital (ROIC) 0.04
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.04

Liquidity (mrq)
Quick Ratio 18.17
Current Ratio 18.84

Balance Sheet (mrq) ($M)
Current Assets 936.11
Assets 1,166.31
Liabilities 55.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 117.61
Operating Income -54.27
Net Income 41.08

Cash Flow Statement (mra) ($M)
Cash From Operations 18.84
Cash from Investing 175.15
Cash from Financing -1.23

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-25 13D/A Altria Group, Inc. 41.00 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-01 218,790 760,567 28.77
2025-03-31 367,394 1,526,632 24.07
2025-03-28 267,546 907,405 29.48
2025-03-27 701,496 1,609,374 43.59

(click for more detail)

Similar Companies
CLYM – Climb Bio, Inc. CMRX – Chimerix, Inc.
CRMD – CorMedix Inc. CRSP – CRISPR Therapeutics AG
CRVS – Corvus Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Cronos Group